Karma Oncology Ltd
Karma Oncology is a specialized oncology clinical development organisation headquartered in Scotland with offices in Ireland, Netherlands and USA.
Karma offers a bespoke service, from the preparation of clinical development plans through design, set-up & execution of clinical trials. Our expertise includes the design and execution of autologous and CAR-T cell therapy studies in Europe and North America.
The company was founded in 2012 by Dr Karen J Williams, who, while working as a Sponsor, had become increasingly frustrated by the inevitable constraints and rigidity smaller companies can experience being lost and forgotten in larger CRO’s. Utilizing her 30 years’ experience in pharma and CRO industries, Dr Williams started Karma Oncology to ensure smaller biotech’s get the service and attention they deserve. She has surrounded herself with like-minded professionals and built a team, who, like herself have a passion for this work and are nowledgeable, Adaptable, Reliable, Motivated and Accountable.
Dr Karen WilliamsCEO
Scottish Development International
Scottish Development International (SDI) is part of Scotland’s main enterprise, innovation and investment agency and works to help international companies find partners in Scotland and Scottish companies develop their business overseas. SDI also works to attract inward investment and knowledge to Scotland in order to help the economy grow.
SDI has a network of offices around the world and provides a wide range of support services covering each phase of international activity, including: business mentoring, market intelligence, business location information and investor aftercare.
The Scottish Life Sciences sector counts more than 700 organisations and 35,000 people with particular strengths in supporting drug discovery and development, regenerative medicine/stem cells, animal health, medical devices, digital health and clinical translational medicine.